Purchase product: USA Store
|Product Code||Pack Size||Price in
|Price in EMEA|
|04-0016||10 mg||USD $ 51.00||GBP £ 39.48||EUR € 44.81|
Prices do not include shipping and handling charges.
Stemolecule Doxycycline hyclate (dox) is a broad spectrum antibiotic derivative of tetracycline and an inhibitor of matrix metalloproteinases1. Tetracycline-controlled transcriptional activation is a method of inducible expression whereby transcription is reversibly turned on or off in the presence of tetracycline or one of its derivatives such as dox2. For this type of reprogramming method, dox-inducible lentiviral reagents are used to induce the expression of virally transduced genes and generate induced pluripotent stem (iPS) cells from somatic cells3-7.
Product Name: Stemolecule Doxycycline Hyclate
Catalog Number: 04-0016
Size: 10 mg
Alternate Name(s): (2Z,4S,5S,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; ethanol; hydrochloride
Chemical Formula: C22H24N2O8· HCl · ½(H2O) · ½(C2H6O)
Molecular Weight: 512.94
CAS Number: 24390-14-5
Purity: Greater than 98% by TLC analysis
Formulation: Yellow to yellow with a green cast powder
Solubility: For a 10 mM stock solution of doxycycline hyclate, reconstitute the compound by adding 1.95 mL of water to the entire contents of the vial.
Storage and Stability: Store powder at 4 °C protected from light. Information about the stability of Stemolecules in solution is largely not available. As a general guideline, we recommend that stock solution be freshly made and stored in aliquots at −20 °C, protected from light. The effect of storage of stock solutions should be verified for each application.
Quality Control: The purity of doxycycline hyclate was determined by TLC analysis. The accurate mass was determined by mass spectrometry. Cellular toxicity of doxycycline hyclate was tested on mouse embryonic stem cells.
Stem Cell Reagents
3D Cell Culture
Zara Puckrin, BSc / 8 June 2021
Zara Puckrin, BSc / 31 May 2021
Lydia Costello, PhD / 25 May 2021
21 June 2021
24 May 2021
© 2021 REPROCELL Inc. All rights reserved.